Abstract
In the past 20 years, cancer medicine has been revolutionized by an array of new treatments, ranging from monoclonal antibodies to novel immunotherapies like CAR T-cell therapy, and targeted therapies like tyrosine kinase inhibitors. Some have played such a major role in improving survival rates that they have now been added to the WHO Model List of Essential Medicines.
Key Data
-
Publication Date26 June 2025
-
Primary AuthorJuergen Eckhardt
-
SourceForbes.com
-
LanguageEnglish
Click below to visit original source: